Gamco Investors INC. ET AL Sells 16,244 Shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY)

Gamco Investors INC. ET AL reduced its position in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 14.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 98,976 shares of the medical instruments supplier’s stock after selling 16,244 shares during the quarter. Gamco Investors INC. ET AL’s holdings in DENTSPLY SIRONA were worth $5,276,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in XRAY. Vanguard Group Inc. grew its stake in shares of DENTSPLY SIRONA by 7.0% during the 2nd quarter. Vanguard Group Inc. now owns 25,969,056 shares of the medical instruments supplier’s stock valued at $1,515,556,000 after purchasing an additional 1,688,546 shares during the period. Nuveen Asset Management LLC bought a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at about $64,278,000. Eagle Asset Management Inc. grew its stake in shares of DENTSPLY SIRONA by 2,650.9% during the 2nd quarter. Eagle Asset Management Inc. now owns 952,733 shares of the medical instruments supplier’s stock valued at $55,601,000 after purchasing an additional 918,100 shares during the period. Parnassus Investments CA grew its stake in shares of DENTSPLY SIRONA by 54.8% during the 3rd quarter. Parnassus Investments CA now owns 2,403,989 shares of the medical instruments supplier’s stock valued at $128,157,000 after purchasing an additional 850,850 shares during the period. Finally, Robeco Institutional Asset Management B.V. grew its stake in shares of DENTSPLY SIRONA by 1,307.0% during the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 886,027 shares of the medical instruments supplier’s stock valued at $51,713,000 after acquiring an additional 823,052 shares during the period. Institutional investors and hedge funds own 93.46% of the company’s stock.

NASDAQ XRAY traded up $0.10 during trading hours on Friday, reaching $57.18. The company’s stock had a trading volume of 18,056 shares, compared to its average volume of 1,176,888. The firm’s 50-day moving average price is $53.74 and its 200-day moving average price is $54.15. The company has a quick ratio of 1.39, a current ratio of 2.08 and a debt-to-equity ratio of 0.30. DENTSPLY SIRONA Inc has a 1 year low of $34.93 and a 1 year high of $60.15. The company has a market capitalization of $12.31 billion, a price-to-earnings ratio of 28.34, a PEG ratio of 1.97 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.57 EPS for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.07. DENTSPLY SIRONA had a return on equity of 9.19% and a net margin of 2.67%. The company had revenue of $962.10 million for the quarter, compared to analysts’ expectations of $940.38 million. During the same period in the previous year, the firm earned $0.38 EPS. The firm’s revenue was up 3.6% compared to the same quarter last year. Equities research analysts anticipate that DENTSPLY SIRONA Inc will post 2.39 EPS for the current fiscal year.

A number of brokerages recently issued reports on XRAY. Evercore ISI began coverage on DENTSPLY SIRONA in a research note on Friday, July 26th. They set an “in-line” rating for the company. Wellington Shields upgraded DENTSPLY SIRONA from a “hold” rating to a “gradually accumulate” rating in a research note on Friday, August 2nd. Barrington Research reiterated a “buy” rating and set a $63.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, August 5th. BidaskClub downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Tuesday, October 29th. Finally, ValuEngine downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Wednesday, October 2nd. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company’s stock. DENTSPLY SIRONA currently has an average rating of “Hold” and a consensus target price of $55.75.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: Which market index is the best?

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.